«What we did in this paper is
engineer our sensor to be about 15 times better than a previous version,
and then compared it against a blood biomarker in a mouse model of ovarian cancer to
show that we could beat it,» says Sangeeta Bhatia, the John
and Dorothy Wilson Professor of Health Sciences
and Technology
and Electrical Engineering
and Computer Science, a member of MIT's Koch Institute for Integrative Cancer Research
and Institute for Medical Engineering
and Science,
and the senior author of the study.